Key Players in the Asia Pacific Mucormycosis Market, Segmentation, Size, Shares and Revenue Analysis

The Mucormycosis is previously called as zygomycosis which is a rare but lethal angio-invasive infection which is caused because of group of fungi called as mucormycetes. Spores of these ubiquitous fungi are generally seen in soil, fallen leaves, compost, animal dung and air it may be inhaled and then infect the lungs, sinuses and extend into the brain and eyes. Less frequently, infection may develop when the spores enter the body by a cut or an open wound. It is not a contagious disease i.e. it cannot spread from one person to another. Mucormycosis is an aggressive, life-threatening infection requiring quick diagnosis and early treatment.

To know the scope of our report get a sample on https://www.axiommrc.com/request-for-sample/10886-asia-pacific-mucormycosis-market-report

MARKET DYNAMICS- ASIA PACIFIC MUCORMYCOSIS MARKET

The Asia Pacific mucormycosis market is witnessing rapid growth during forecast period of 2021 to 2027. The mucormycosis will leads to blindness, organ dysfunction and other problems which may need surgical treatment sometimes. The dynamic factors such as upsurge in the prevalence of fungal infections is propelling growth of Asia Pacific mucormycosis market. The availability of extensive variety of drugs is also boosting growth of Asia Pacific mucormycosis market. The increasing cases of immunological diseases is also refuelling growth of Asia Pacific mucormycosis market. However, presence of misbranded drugs is hampering growth of Asia Pacific mucormycosis market.

COVID-19 IMPACT ON ASIA PACIFIC MUCORMYCOSIS MARKET

The exclusive COVID-19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the mucormycosis market. In addition, complete analysis of changes on mucormycosis expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on Asia Pacific economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The COVID-19 has almost affected every market is healthcare industries positively or negatively. The mucormycosis market is primarily driven by the emergence of COVID-19 pandemics. Before the pandemic situation, the fungal infection is rare but COVID-19 is causing high healthcare challenges across the globe. The increasing cases of COVID-19 will significantly increase the number of mucormycosis cases across the globe.

ASIA PACIFIC MUCORMYCOSIS MARKET- SEGMENTAL OVERVIEW

The Asia Pacific mucormycosis market is segmented into the species, diagnosis method, drugs, distribution channel and country.

ASIA PACIFIC MUCORMYCOSIS MARKET BY SPECIES

The Asia Pacific mucormycosis market is comprised of species such as rhizopus, cuninghamella, rhizomucor, saksenaea, apophysomyces, lichtheimia, mucor and other species. The saksenaea is also contributing to the growth of Asia Pacific mucormycosis market. The saksenaea is a genus of fungi in the saksenaeaceae family. The species is firstly described in 1953, which is capable of causing severe human infections. It is characterised by the formation of flask-shaped sporangia with columellae and simple, darkly pigmented rhizoids.

ASIA PACIFIC MUCORMYCOSIS MARKET BY DIAGNOSIS METHOD

The Asia Pacific mucormycosis market is comprised on diagnosis method is comprised of diagnosis methods such as magnetic resonance imaging, computed tomography, tissue biopsy and others. The computed tomography is estimated to dominate the market in 2020. The growing prevalence of fungal disease is driving growth of Asia Pacific mucormycosis market by diagnosis method. The rising technological advances is boosting growth of Asia Pacific mucormycosis market. 

ASIA PACIFIC MUCORMYCOSIS MARKET BY DRUGS

The Asia Pacific mucormycosis market is comprised of drugs such as Amphotericin B, isavuconazole, Posaconazole, voriconazole, flucytosine, fluconazole and other drugs. In which flucytosine is also contributing to the growth of Asia Pacific mucormycosis market. The rising cases of mucormycosis is propelling growth of Asia Pacific mucormycosis market. The growing cases of immune suppressant diseases is also boosting growth of Asia Pacific mucormycosis market. 

ASIA PACIFIC MUCORMYCOSIS MARKET BY DISTRIBUTION CHANNELS

The Asia Pacific mucormycosis market is comprised of distribution channels such as hospital pharmacies, retail pharmacies and online pharmacies. In which hospital pharmacies are anticipated to dominate the market in 2020. The increasing patient footfall is propelling growth of Asia Pacific mucormycosis market. The growing rate of admission in hospital for treatment is also boosting growth of Asia Pacific mucormycosis market. The growing number of hospitals is also driving growth of Asia Pacific mucormycosis market. 

ASIA PACIFIC MUCORMYCOSIS MARKET BY COUNTRY

The Asia Pacific mucormycosis market is studied for key countries such as India, China, Japan, Australia and South Korea. In which China followed by India and Japan are anticipated to dominate the market in 2020. The rising disposable income of countries is propelling growth of Asia Pacific mucormycosis market. The growing rate of mucormycosis is also boosting growth of Asia Pacific mucormycosis market. The growing healthcare spending is also driving growth of Asia Pacific mucormycosis market.

KEY PLAYERS IN MUCORMYCOSIS MARKET

The major key players such as Natco Pharmaceuticals, Alembic Pharmaceuticals, Gufic Biosciences, Lyca Pharmaceuticals, Emcure Pharmaceuticals, Bharat Serums And Vaccines, Bdr Pharmaceuticals, Cipla Limited, Lifecare Innovations, Synbiotics Limited, Kamla Lifesciences, Cadila Healthcare Limited and Tlc Pharma Labs among others.

KEY DEVELOPMENTS IN MUCORMYCOSIS MARKET

June 2021: Celon Laboratories launched an alternative drug, Amphotericin B Emulsion for the treatment of mucormycosis. 

May 2021: TLC Pharma, a clinical-stage specialty pharmaceutical company, received approval for the New Drug Application (NDA) for Amphotericin B liposome injection (AmphoTLC), form the Central Drugs Standard Control Organization (CDSCO) of India. The drug can be used in the treatment of fungal infections including mucormycosis infections.

2020: Pfizer Inc. in association with its partner Basilea Pharmaceutica Ltd., launched Cresemba (isavuconazole). The drug is used in mucormycosis and invasive aspergillosis. 

September 2019: U.S. FDA granted Fast Track designations for intravenous (IV) and oral formulations for fosmanogepix (APX001) developed, by Amplyx Pharmaceuticals.

Buy now Asia Pacific Mucormycosis Market Report https://www.axiommrc.com/buy_now/10886-asia-pacific-mucormycosis-market-report

About Us: 

Axiom Market Research & Consulting™ is a full-service market research and data analytics company providing key market intelligence to global companies to take informed business decisions pertaining to their marketing strategy, investments, new product launches, market competition, consumer or end users, social media trends etc.  

Axiom Market Research & Consulting™ offers market research services such as syndicated market research, custom market research, business consulting, and consumer/end user surveys. Under Business to Consumer (B2C) market research offerings, Axiom MRC assists its clients in finding quantitative information/preferences of its brands and services such as, awareness, usages, satisfaction, tracking, ethnicity etc. Axiom MRC offers data collection services through online surveys, social media, data processing and interpretation. 

Axiom MRC with its experienced team of research and data analysts, has delivered more than 5000+ Market Research Projects, 3800+ Data Analytics Projects, 1200+ Business Support Projects and has a 800+ Global Client Base. Axiom Market Research & Consulting™ aims to become the preferred market research and data analytics company by providing key market intelligence solutions for client’s business growth. 

Contact Us:

Axiom Market Research & Consulting™

3 Germay Dr. Ste 4 - 4666

Wilmington DE 19804

U.S.:- + 1 (845) 875-9786

U.K.:- + 44 (0) 20 3286 9707

Email: sales@axiommrc.com

Website: https://www.axiommrc.com/

Blog: https://industrywatch24.com/

          https://readbeyondnews.com/ 

Follow On 

LinkedIn: https://www.linkedin.com/company/axiom-market-research-and-consulting/

Twitter:  https://twitter.com/AxiommrcCom

Comments

Post a Comment

Popular posts from this blog

Freeze Drying Equipment Market: Growth, Opportunities, and Future Outlook

Freeze Drying Equipment Market is segmented based on type, application, and region. The different types of freeze drying equipment include laboratory, pilot, and industrial-scale equipment. The applications of freeze drying equipment include food processing, pharmaceuticals, biotechnology, and others. The market is dominated by the pharmaceutical and biotechnology segments due to the high demand for freeze-dried drugs and vaccines.   Freeze drying, also known as lyophilization, is a dehydration process used to preserve perishable materials such as food, pharmaceuticals, and biologicals. Freeze drying equipment is used to carry out this process, which involves freezing the material and then removing the ice by sublimation. Freeze drying equipment is an essential tool for industries that require long-term storage of perishable materials. The global freeze drying equipment market is expected to grow at a significant rate in the coming years due to the increasing demand for freeze...
Read more

Viral Vector Manufacturing Market Insights, Trends, And Forecasts 2019-2028

Image
Viral vector is the most effective means of gene transfer to modify specific cell type or tissue and can be manipulated to express therapeutic genes. Several virus types are currently being investigated for use to deliver genes to cells to provide either transient or permanent transgene expression. These include adenoviruses, retroviruses, poxviruses, adeno-associated viruses, baculoviruses, and herpes simplex viruses. The choice of virus for routine clinical use depends on the efficiency of transgene expression, ease of production, safety, toxicity, and stability. Furthermore, many types of viral vectors have been used in a wide array of basic and clinical studies, and genetic tools made possible to construct novel viruses intended for gene therapy, but also the development of vaccines. Moreover, in gene therapy, viral vectors can be applied to treat different diseases such as, metabolic diseases, heart defects and neurodegenerative disorders. Additionally, in vaccinology, a growing l...
Read more

Lubricants Market: Size, Segmentation, Key Players and Future Trends

Lubricants are essential fluids that help in reducing friction and wear and tear of machinery and equipment by forming a protective film on the surface. The global lubricants market is expected to grow at a significant pace in the coming years, primarily driven by the increasing demand from various end-use industries such as automotive, industrial, marine, and aerospace. This article will provide an overview of the lubricants market, including its growth drivers, market segmentation, key players, and future trends.   To know the scope of our report get a sample  on https://www.axiommrc.com/request-for-sample/1352-lubricants-market-report   INCREASING DEMAND FROM AUTOMOTIVE INDUSTRY   The automotive industry is the largest consumer of lubricants globally. With the increasing demand for automobiles worldwide, the demand for lubricants is also expected to grow. Lubricants play a crucial role in maintaining the performance of engines and other automotive com...
Read more